The Childrenโs Lung Function Instrument industry trends over the past 18 months reflect a surge in innovation driven by telehealth integration and AI-enabled diagnostics. Strategic partnerships dominated the landscape, with key players like Teleflex collaborating with pediatric healthcare providers to develop portable, IoT-enabled spirometers tailored for remote monitoring. Mergers and acquisitions saw ResMed acquire Pediatric Diagnostics Inc., consolidating expertise in non-invasive lung function testing. Regulatory shifts, including the FDAโs 2023 update to pediatric device safety protocols, spurred R&D investments in age-specific accuracy calibration. Concurrently, enterprises prioritized user-centric designs, introducing wearable sensors and gamified apps to improve pediatric compliance. Funding momentum accelerated, with BreathTech securing $45M in Series B rounds to scale its AI-driven lung function analytics platform. As hospitals and clinics adopt hybrid care models, demand for compact, cost-effective devices is projected to grow, pushing manufacturers to balance precision with accessibility in emerging markets.